AKT1 and acute lymphoblastic leukemia: We previously found that insulin-like growth factor 1 (IGF-1), which is highly expressed in BM, increased the resistance capacity of pre-B ALL cells to chemotherapy via the PI3K/AKT pathway (Zhiwu Jang unpublished).